nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—DRD2—nicotine dependence	0.884	1	CbGaD
Fenoldopam—DRD5—Dopamine receptors—DRD2—nicotine dependence	0.00971	0.0982	CbGpPWpGaD
Fenoldopam—DRD1—Dopamine receptors—DRD2—nicotine dependence	0.00645	0.0652	CbGpPWpGaD
Fenoldopam—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00452	0.0457	CbGpPWpGaD
Fenoldopam—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00291	0.0294	CbGpPWpGaD
Fenoldopam—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00237	0.024	CbGpPWpGaD
Fenoldopam—DRD5—Monoamine GPCRs—DRD2—nicotine dependence	0.00215	0.0217	CbGpPWpGaD
Fenoldopam—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00209	0.0211	CbGpPWpGaD
Fenoldopam—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.0019	0.0192	CbGpPWpGaD
Fenoldopam—Leukocytosis—Varenicline—nicotine dependence	0.00188	0.108	CcSEcCtD
Fenoldopam—ADRA1D—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00188	0.019	CbGpPWpGaD
Fenoldopam—DRD5—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0018	0.0182	CbGpPWpGaD
Fenoldopam—ADRA1B—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00156	0.0158	CbGpPWpGaD
Fenoldopam—DRD1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00146	0.0148	CbGpPWpGaD
Fenoldopam—DRD1—Monoamine GPCRs—DRD2—nicotine dependence	0.00143	0.0144	CbGpPWpGaD
Fenoldopam—ADRA1D—Monoamine GPCRs—DRD2—nicotine dependence	0.00141	0.0142	CbGpPWpGaD
Fenoldopam—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00139	0.014	CbGpPWpGaD
Fenoldopam—ADRA2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00127	0.0128	CbGpPWpGaD
Fenoldopam—DRD1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0012	0.0121	CbGpPWpGaD
Fenoldopam—ADRA2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00119	0.012	CbGpPWpGaD
Fenoldopam—ADRA1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00118	0.012	CbGpPWpGaD
Fenoldopam—ADRA1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00117	0.0118	CbGpPWpGaD
Fenoldopam—Hypokalaemia—Varenicline—nicotine dependence	0.00117	0.0668	CcSEcCtD
Fenoldopam—Angina pectoris—Varenicline—nicotine dependence	0.00108	0.0618	CcSEcCtD
Fenoldopam—ADRA2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00107	0.0108	CbGpPWpGaD
Fenoldopam—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00104	0.0105	CbGpPWpGaD
Fenoldopam—ADRA2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000998	0.0101	CbGpPWpGaD
Fenoldopam—ADRA1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000982	0.00992	CbGpPWpGaD
Fenoldopam—Acute coronary syndrome—Varenicline—nicotine dependence	0.000974	0.0558	CcSEcCtD
Fenoldopam—Myocardial infarction—Varenicline—nicotine dependence	0.000969	0.0554	CcSEcCtD
Fenoldopam—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.000964	0.00974	CbGpPWpGaD
Fenoldopam—Bradycardia—Varenicline—nicotine dependence	0.000903	0.0517	CcSEcCtD
Fenoldopam—DRD5—GPCR ligand binding—TAS2R16—nicotine dependence	0.000887	0.00896	CbGpPWpGaD
Fenoldopam—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000872	0.00881	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000867	0.00876	CbGpPWpGaD
Fenoldopam—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00081	0.00819	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00081	0.00818	CbGpPWpGaD
Fenoldopam—Back pain—Varenicline—nicotine dependence	0.000747	0.0428	CcSEcCtD
Fenoldopam—Muscle spasms—Varenicline—nicotine dependence	0.000743	0.0425	CcSEcCtD
Fenoldopam—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000735	0.00743	CbGpPWpGaD
Fenoldopam—Palpitations—Varenicline—nicotine dependence	0.000683	0.0391	CcSEcCtD
Fenoldopam—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000658	0.00665	CbGpPWpGaD
Fenoldopam—Chest pain—Varenicline—nicotine dependence	0.000658	0.0376	CcSEcCtD
Fenoldopam—Anxiety—Varenicline—nicotine dependence	0.000655	0.0375	CcSEcCtD
Fenoldopam—Tachycardia—Varenicline—nicotine dependence	0.000615	0.0352	CcSEcCtD
Fenoldopam—Hyperhidrosis—Varenicline—nicotine dependence	0.000609	0.0349	CcSEcCtD
Fenoldopam—DRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000589	0.00596	CbGpPWpGaD
Fenoldopam—Hypotension—Varenicline—nicotine dependence	0.000589	0.0337	CcSEcCtD
Fenoldopam—ADRA1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.000581	0.00588	CbGpPWpGaD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000573	0.00579	CbGpPWpGaD
Fenoldopam—Insomnia—Varenicline—nicotine dependence	0.00057	0.0326	CcSEcCtD
Fenoldopam—Dyspnoea—Varenicline—nicotine dependence	0.000562	0.0322	CcSEcCtD
Fenoldopam—Constipation—Varenicline—nicotine dependence	0.000539	0.0308	CcSEcCtD
Fenoldopam—ADRA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.000525	0.0053	CbGpPWpGaD
Fenoldopam—Gastrointestinal pain—Varenicline—nicotine dependence	0.000515	0.0295	CcSEcCtD
Fenoldopam—DRD5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000501	0.00507	CbGpPWpGaD
Fenoldopam—Abdominal pain—Varenicline—nicotine dependence	0.000498	0.0285	CcSEcCtD
Fenoldopam—Body temperature increased—Varenicline—nicotine dependence	0.000498	0.0285	CcSEcCtD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000491	0.00496	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00049	0.00496	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.000483	0.00488	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—TAS2R16—nicotine dependence	0.000455	0.0046	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000455	0.00459	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000445	0.0045	CbGpPWpGaD
Fenoldopam—Diarrhoea—Varenicline—nicotine dependence	0.000431	0.0247	CcSEcCtD
Fenoldopam—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000429	0.00433	CbGpPWpGaD
Fenoldopam—Dizziness—Varenicline—nicotine dependence	0.000417	0.0239	CcSEcCtD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000414	0.00419	CbGpPWpGaD
Fenoldopam—Vomiting—Varenicline—nicotine dependence	0.000401	0.0229	CcSEcCtD
Fenoldopam—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000398	0.00402	CbGpPWpGaD
Fenoldopam—Headache—Varenicline—nicotine dependence	0.000395	0.0226	CcSEcCtD
Fenoldopam—DRD5—GPCR downstream signaling—FGD1—nicotine dependence	0.000393	0.00397	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000381	0.00385	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000376	0.0038	CbGpPWpGaD
Fenoldopam—Nausea—Varenicline—nicotine dependence	0.000374	0.0214	CcSEcCtD
Fenoldopam—DRD5—GPCR ligand binding—OPRM1—nicotine dependence	0.000374	0.00378	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000365	0.00369	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—FGD1—nicotine dependence	0.000357	0.00361	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000355	0.00359	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000343	0.00347	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000341	0.00345	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000339	0.00343	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—DRD2—nicotine dependence	0.000336	0.0034	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000333	0.00337	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000329	0.00332	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000326	0.0033	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000322	0.00325	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000317	0.0032	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000312	0.00315	CbGpPWpGaD
Fenoldopam—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00031	0.00313	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000302	0.00306	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.000298	0.00302	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000297	0.003	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000291	0.00294	CbGpPWpGaD
Fenoldopam—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000287	0.00291	CbGpPWpGaD
Fenoldopam—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000277	0.0028	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000277	0.0028	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000277	0.0028	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000275	0.00278	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000273	0.00276	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000272	0.00274	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000271	0.00274	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—DRD2—nicotine dependence	0.00027	0.00273	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000269	0.00272	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TAS2R16—nicotine dependence	0.000269	0.00272	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000267	0.0027	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000264	0.00267	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000261	0.00264	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000258	0.00261	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000257	0.0026	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000252	0.00254	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000251	0.00254	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000248	0.00251	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000248	0.0025	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.000247	0.00249	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000246	0.00249	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000245	0.00248	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000245	0.00248	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000242	0.00245	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000237	0.0024	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000237	0.0024	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000236	0.00238	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.000234	0.00237	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000233	0.00235	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000233	0.00235	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000229	0.00231	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000228	0.00231	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000225	0.00228	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000225	0.00227	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000221	0.00224	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00022	0.00223	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00022	0.00222	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000217	0.0022	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000214	0.00216	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000211	0.00214	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—OPRM1—nicotine dependence	0.000211	0.00214	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—FGD1—nicotine dependence	0.000211	0.00213	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00021	0.00212	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000207	0.00209	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000204	0.00207	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000203	0.00206	CbGpPWpGaD
Fenoldopam—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.0002	0.00203	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0002	0.00202	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000197	0.002	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000197	0.00199	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000196	0.00198	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000194	0.00196	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000193	0.00195	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—OPRM1—nicotine dependence	0.000192	0.00194	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00019	0.00192	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000188	0.0019	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKR1B10—nicotine dependence	0.000186	0.00188	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000186	0.00188	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000181	0.00183	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.00018	0.00181	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000179	0.00181	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000179	0.00181	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000177	0.00179	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000177	0.00178	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000176	0.00178	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000173	0.00174	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000172	0.00173	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000168	0.0017	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00016	0.00162	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.00016	0.00162	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000159	0.00161	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000159	0.00161	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—DRD2—nicotine dependence	0.000153	0.00154	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.000149	0.00151	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000149	0.0015	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000147	0.00149	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000146	0.00148	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00014	0.00142	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—FGD1—nicotine dependence	0.00014	0.00142	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—DRD2—nicotine dependence	0.000139	0.0014	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000138	0.0014	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000138	0.0014	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000135	0.00136	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—WASF2—nicotine dependence	0.000131	0.00133	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000131	0.00132	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00013	0.00131	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.000127	0.00129	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—WASF1—nicotine dependence	0.000126	0.00127	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000126	0.00127	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000125	0.00126	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000125	0.00126	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	0.000124	0.00125	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000122	0.00123	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000121	0.00123	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000121	0.00122	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000117	0.00118	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.000117	0.00118	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000115	0.00116	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.000115	0.00116	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.000115	0.00116	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000114	0.00115	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—OPRM1—nicotine dependence	0.000113	0.00115	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.00011	0.00111	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000106	0.00107	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000106	0.00107	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGD1—nicotine dependence	0.000106	0.00107	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000104	0.00106	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000103	0.00104	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.00103	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.00103	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	0.000101	0.00103	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000101	0.00102	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.0001	0.00101	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	9.62e-05	0.000973	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	9.49e-05	0.000959	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	9.47e-05	0.000957	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	9.35e-05	0.000945	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CYP2A7—nicotine dependence	9.3e-05	0.00094	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	9.27e-05	0.000937	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD2—nicotine dependence	9.22e-05	0.000931	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	9.09e-05	0.000919	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	9.04e-05	0.000914	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	9.01e-05	0.00091	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—WASF2—nicotine dependence	8.72e-05	0.000882	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	8.62e-05	0.000871	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	8.61e-05	0.00087	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	8.44e-05	0.000853	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	8.37e-05	0.000846	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—WASF1—nicotine dependence	8.36e-05	0.000845	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	8.31e-05	0.00084	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	8.25e-05	0.000834	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	8.21e-05	0.00083	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD2—nicotine dependence	8.19e-05	0.000828	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	7.77e-05	0.000785	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	7.67e-05	0.000775	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	7.55e-05	0.000763	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—OPRM1—nicotine dependence	7.53e-05	0.000761	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	7.45e-05	0.000753	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	7.43e-05	0.000751	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	7.38e-05	0.000746	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	7.26e-05	0.000734	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	7.14e-05	0.000722	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	6.96e-05	0.000703	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	6.86e-05	0.000693	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	6.85e-05	0.000692	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	6.71e-05	0.000678	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	6.7e-05	0.000678	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—WASF2—nicotine dependence	6.59e-05	0.000666	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	6.35e-05	0.000641	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—WASF1—nicotine dependence	6.31e-05	0.000638	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	6.27e-05	0.000633	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	6.23e-05	0.00063	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	6.17e-05	0.000623	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	6.08e-05	0.000615	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	5.9e-05	0.000596	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—OPRM1—nicotine dependence	5.69e-05	0.000575	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	5.65e-05	0.000571	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	5.48e-05	0.000554	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD2—nicotine dependence	5.44e-05	0.00055	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	5.37e-05	0.000543	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	5.09e-05	0.000514	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	4.85e-05	0.00049	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	4.53e-05	0.000458	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	4.46e-05	0.000451	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	3.96e-05	0.0004	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	3.68e-05	0.000372	CbGpPWpGaD
